Nirsevimab Effective for Reducing Burden of RSV in Infants
Nirsevimab associated with lower odds of RSV-related hospitalization, ICU admission, lower respiratory tract infection incidence
Study IDs Trends in 2015 to 2023 Mortality for Chronic Liver Disease
Increasing trend in metabolic dysfunction-associated steatotic liver disease-related mortality steeper than that for alcohol-related liver disease mortality
Live Zoster Vaccination Linked to Lower Risk for Cardiovascular Events
In a recent study, protective association lasted for up to eight years, with greatest reduction seen at two to three years postvaccination
North Dakota Becomes the Latest State to Report Measles Outbreak
Total of 935 cases of measles have been reported so far this year in the United States
Targeted Grant Terminations Have Affected 694 NIH Grants
Terminations resulted in $1.81 billion in terminated grant funding; 30.0 percent had not been expended at time of termination
Dr. Vinay Prasad to Head FDA Vaccine, Biologics Division
Top FDA Inspection Official to Retire Amid Staff Frustration
Europe Launches $565 Million Campaign to Attract U.S. Scientists
Quality Improvement Program Aids Antibiotic Duration for Common Infections in Children
Findings show feasibility for acute otitis media and community-acquired pneumonia across care settings
Sustainable Development Strategies Can Reduce Global Antimicrobial Resistance
Sustainable development efforts such as lowering out-of-pocket health expenses can reduce future prevalence of AMR by 5.1 percent
